MedPath

Percutaneous Transluminal Forceps Biopsy

Completed
Conditions
Oncology
Biliary Stricture
Biopsy Wound
Registration Number
NCT06039670
Lead Sponsor
University Hospital, Caen
Brief Summary

To evaluate during a 7 months period the efficacy, safety and accuracy of percutaneous transluminal forceps biopsy combined with transhepatic biliary drainage in patients with biliary stricture

Detailed Description

Biological parameters of liver function, histopathology of specimens, comparison with others clinical and pathological data (imaging follow up, percutaneous biopsy, surgical biopsy, endoscopic biopsy) were recorded Comparison between pathological findings of surgery or endoscopy or percutaneous biopsy and specimens coming from biliary forceps biopsy follow up of the patient 12 months after biopsy Evaluation of complications, accuracy

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients with biliary strictures without histology available
Exclusion Criteria
  • Pregnant patients
  • Children

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of PTBD7 days

Efficacy of PTBD : bilirubinemia after PTFB at Day 7

incidence of PTFB-related adverse eventsup to 1 month after procedure

Number of patients with PTFB related adverse-events as assessed by Society of Interventional Radiology Standards of Practice Committee classification

accuracy for percutaneous biliary biopsy (PTFB)from baseline up to 1 month

Accuracy of PTFB : percentage of true positive and true negative results by pathologists

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath